MXCT vs TRV · rev $38.6M vs P/E 14, rev $48.83B
MaxCyte Inc (MXCT) versus The Travelers Companies Inc (TRV) — a side-by-side from cached financials, not a winner call.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
The Travelers Companies Inc (TRV) is a insurance - property & casualty company listed on US.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
Latest reported TRV revenue for 2025-12-31 was $48.83B. Net income was $6.29B. Revenue was up 5.2% from 2024-12-31 to 2025-12-31. TRV currently screens at market cap $59.84B and trailing P/E 14.4.
MXCT currently screens at market cap $124.3M. TRV currently screens at market cap $59.84B and trailing P/E 14.4.
Not investment advice. Open the MXCT and TRV stock pages for the full models.
Not investment advice.